We are live on ! Find out more
SIC

SJS Investment Consulting Portfolio holdings

AUM $919M
1-Year Est. Return 23.4%
This Fund
S&P 500
This Quarter Est. Return
+12.81%
1 Year Est. Return
+23.4%
3 Year Est. Return
+63.82%
5 Year Est. Return
10 Year Est. Return
AUM
$919M
AUM Growth
+$100M
Cap. Flow
+$8.56M
Cap. Flow %
0.93%
Top 10 Hldgs %
73.95%
Holding
3,000
New
529
Increased
1,513
Reduced
448
Closed
116
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAAX icon
626
VanEck Inflation Allocation ETF
RAAX
$1.2B
$32.1K ﹤0.01%
808
+311
+63% +$12.8K
AVSE icon
627
Avantis Responsible Emerging Markets Equity ETF
AVSE
$216M
$32K ﹤0.01%
391
+37
+10% +$2.85K
NOV icon
628
NOV
NOV
$7.38B
$31.9K ﹤0.01%
1,722
+1,647
+2,196% +$32.8K
BKH icon
629
Black Hills Corp
BKH
$5.62B
$31.6K ﹤0.01%
425
+417
+5,213% +$30.7K
QXO
630
QXO Inc
QXO
$16.6B
$31.5K ﹤0.01%
1,823
-448
-20% -$8.34K
RBLX icon
631
Roblox
RBLX
$26.5B
$31.2K ﹤0.01%
574
+233
+68% +$11.6K
LBTYA icon
632
Liberty Global Class A
LBTYA
$3.46B
$31.2K ﹤0.01%
2,743
+2,452
+843% +$29.3K
CSX icon
633
CSX Corp
CSX
$92.8B
$31.1K ﹤0.01%
655
-1,270
-66% -$57.3K
UPS icon
634
United Parcel Service
UPS
$89.1B
$31K ﹤0.01%
289
-197
-41% -$20.5K
F icon
635
Ford
F
$55.8B
$30.8K ﹤0.01%
2,217
-416
-16% -$5.61K
GMED icon
636
Globus Medical
GMED
$11.7B
$30.7K ﹤0.01%
388
-70
-15% -$5.95K
CHE icon
637
Chemed
CHE
$7.18B
$30.3K ﹤0.01%
65
+29
+81% +$12.2K
DD icon
638
DuPont de Nemours
DD
$19.1B
$30.2K ﹤0.01%
223
+50
+29% +$7.1K
CLF icon
639
Cleveland-Cliffs
CLF
$7.13B
$30.2K ﹤0.01%
3,221
+135
+4% +$1.49K
IUSV icon
640
iShares Core S&P US Value ETF
IUSV
$27.8B
$30.1K ﹤0.01%
273
-228
-46% -$24.7K
OVV icon
641
Ovintiv
OVV
$17.6B
$30K ﹤0.01%
569
+106
+23% +$6.05K
OKLO
642
Oklo
OKLO
$7.74B
$29.8K ﹤0.01%
569
+301
+112% +$18.8K
SHAK icon
643
Shake Shack
SHAK
$2.89B
$29.7K ﹤0.01%
530
+452
+579% +$34K
BABA icon
644
Alibaba
BABA
$317B
$29.7K ﹤0.01%
309
+7
+2% +$877
SEDG icon
645
SolarEdge
SEDG
$1.98B
$29.5K ﹤0.01%
+504
New +$26.4K
BITQ icon
646
Bitwise Crypto Industry Innovators ETF
BITQ
$372M
$29.4K ﹤0.01%
1,200
DHR icon
647
Danaher
DHR
$147B
$29.3K ﹤0.01%
154
-127
-45% -$23.1K
VRTX icon
648
Vertex Pharmaceuticals
VRTX
$133B
$29.3K ﹤0.01%
59
+28
+90% +$12.4K
REGN icon
649
Regeneron Pharmaceuticals
REGN
$83.2B
$29.3K ﹤0.01%
47
-19
-29% -$12.9K
RBRK icon
650
Rubrik
RBRK
$20.2B
$29.3K ﹤0.01%
365
+275
+306% +$17.3K

Similar funds

SJS Investment Consulting's Q2 2026 Portfolio in Review

As of Q2 2026, SJS Investment Consulting held 3,000 positions worth $919M, up 12% from $819M the previous quarter. Its ten largest holdings account for 74% of the portfolio.

SJS Investment Consulting's Q2 2026 filing shows 529 new, 1,513 increased, 448 reduced and 116 closed positions. Its largest new stake was Kestra Medical Technologies: 20,060 shares worth $510K. The largest sale was Dimensional Short-Duration Fixed Income ETF, an estimated $17.6M.

By sector, the portfolio is most concentrated in Technology at 5.3% of assets, up from 5% a quarter earlier, followed by Healthcare and Consumer Staples.

  • SJS Investment Consulting's largest Q2 2026 buy was Kestra Medical Technologies: 20,060 shares worth $510K.
  • SJS Investment Consulting added most to Dimensional US Core Equity 2 ETF in Q2 2026, an estimated $6.25M increase.
  • SJS Investment Consulting's biggest Q2 2026 reduction was Dimensional Short-Duration Fixed Income ETF, cutting an estimated $17.6M.
  • SJS Investment Consulting fully exited Vanguard Short Duration Bond ETF in Q2 2026, selling an estimated $299K.
  • SJS Investment Consulting's ten largest holdings make up 74% of its $919M portfolio in Q2 2026.
  • SJS Investment Consulting opened 529 new positions and closed 116 in Q2 2026.
  • SJS Investment Consulting's portfolio value rose 12% quarter-over-quarter to $919M.

Based on SJS Investment Consulting's 13F filing for Q2 2026, filed 22 Jul 2026.